Skip to main content

Table 3 Univariated regression model between Lp-PLA 2 and cardiometabolic factors

From: Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study

  Lp-PLA2
  R2 P* β
BMI, kg/m 2 0.038 0.003 0.195
WC, cm 0.073 0.000 0.270
Fat mass,% 0.034 0.004 0.186
TC, mg/dL 0.035 0.004 0.186
LDL-C, mg/dL 0.016 0.051 0.128
HDL-C, mg/dL 0.001 0.671 −0.028
TG, mg/dL 0.008 0.163 0.091
TG/HDL-C 0.007 0.199 0.084
LDL-C/HDL-C 0.010 0.121 0.121
TC/HDL-C 0.018 0.042 0.133
Non HDL-C 0.022 0.022 0.149
HDL-C/ApoAI 0.001 0.585 0.036
Apo AI, mg/dL 0.019 0.038 −0.137
Apo B, mg/dL 0.082 0.000 0.293
Apo B/Apo AI 0.118 0.000 0.343
LDL-C/ApoB 0.000 0.775 −0.019
LDL(−), mg/mL 0.001 0.706 0.025
Anti LDL(−), mg/mL 0.013 0.078 −0.115
HDL size , nm 0.085 0.000 −0.291
Insulin, uU/mL 0.039 0.002 0.198
Glucose, mg/dL 0.019 0.034 0.138
HOMA-IR 0.047 0.001 0.216
  1. BMI, Body Mass Index; WC, waist circumference, HOMA-IR, homeostasis model assessment of insulin resistance; TC, total cholesterol; TG, triglycerides; LDL, low density lipoprotein; HDL, high density lipoprotein.
  2. Variables in log form, except for percentages. *Significant level (P < 0.05).